The stock of the week: “Guardant Health Inc”

The Stock of the week: “Guardant Health Inc”

 Guardant Health Inc is our “stock of the week” this week. It is a precision oncology company focused on the treatment of cancer using advanced data analytics. The company was founded in Palo Alto in 2012. The results of studies using their portfolio of blood tests and real-world data are being presented in the coming days at the World Conference on Lung Cancer.  

• Financial social media sentiment is “very positive” in both absolute and relative terms – on its own and when compared to the sentiment of the sector and the sentiment of the stock index.

• Analysts' consensus rating is "buy" - out of the 16 bank analysts covering the company, 14 recommend buying the stock and 2 suggest holding. The upside potential of the stock price expected by the analysts on average over the next 6-12 months is currently 84.87% (reference close of business 08/08/2022).

• Attention buzz is currently “High”.